Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review DOI
Huihui Liu, Sha Li, Jian‐Jun Li

et al.

Drugs, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review DOI
Huihui Liu, Sha Li, Jian‐Jun Li

et al.

Drugs, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

0